Cognate BioServices, and its gene therapy division Cobra Biologics Announce Major Expansion of Manufacturing Facilities in US and Europe
Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project
Cobra...
BLOG: Cobra Granted MHRA Licence for Commercial Supply of a Client's Product
Cobra Biologics has been granted a Commercial Licence from the UK Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture and...
INTERVIEW: Thomas Moore, Sky News, Reports on the Fight Against COVID-19
On Wednesday 22nd April 2020, Peter Coleman sat down with Thomas Moore, Science and Medical Correspondent Sky News, to discuss biologics...
Cobra Biologics Is Proud to Be Part of a Consortium to Rapidly Develop a COVID-19 Vaccine
• ChAdOx1 consortium, led by the Jenner Institute, working to produce adenoviral vaccine
• Fast-tracked clinical trials of ChAdOx1 to begin in...
Room for Improvement: Tackling Sub-Optimal Downstream Process Unit Operations for Viral Vectors
Earlier this year, BioInsights hosted an expert roundtable featuring Dr Clive Glover (Pall), Dr Damian Marshall (Cell and Gene Therapy Catapult)...
Advanced Therapies Manufacturing Taskforce
As you may be aware Cobra Biologics has been intrinsically linked to Cell and Gene Therapy product development for the last 30 years, initially...



